Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shingo Shinagawa"'
Autor:
Teruo Kirikae, Kenji Narahara, Akitomo Miyamoto, Sunao Mori, Tohru Miyoshi-Akiyama, Tetsu Yamashiro, Shingo Shinagawa, Hirotake Kitajima, Le Quynh Mai
Publikováno v:
Influenza and Other Respiratory Viruses
Please cite this paper as: Miyoshi-Akiyama et al. (2012) Discrimination of influenza A subtype by antibodies recognizing host-specific amino acids in the viral nucleoprotein. Influenza and Other Respiratory Viruses 6(6), 434–441. Background Nucleop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06018e3dda58f18048b8f5f0b039f0d0
Autor:
Hanako Koga, Takafumi Hara, Taka-aki Koshimizu, Shingo Shinagawa, Chisato Itsubo, Keiko Sadakane, Akira Hirasawa, Hiroshi Nose, Gozoh Tsujimoto
Publikováno v:
Biochemical and biophysical research communications. 365(1)
GPR40 is G protein-coupled receptor whose endogenous ligands have recently been identified as free fatty acids (FFAs), and it has been implicated to play an important role in FFA-mediated enhancement of glucose-stimulated insulin release. We have dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594747338dc1d18d4b5e1f41ef8d5106
https://pubmed.ncbi.nlm.nih.gov/17980148
https://pubmed.ncbi.nlm.nih.gov/17980148
Autor:
Shingo Shinagawa, Fumio Mizutani, Tomoyuki Yasukawa, Shingo Inadumi, Hiroshi Nose, Rie Harada
Publikováno v:
Chemistry Letters. 39:88-89
A novel immunosensor is presented based on a charge accumulation system using an electrode modified with a polymer containing [osmium(4,4′-dimethyl-2,2′-bipyridine)2chloride]+/2+ and horseradish pe...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a40841a5261a03f7306806ecd53d0727
https://doi.org/10.1246/cl.2010.88
https://doi.org/10.1246/cl.2010.88
Autor:
Shingo Shinagawa, Kazufumi Honda, Tesshi Yamada, Koji Tsuta, Akihiko Miyanaga, Akihiko Gemma, Hitoshi Tsuda, Hisao Asamura, Akitomo Miyamoto, Mari Masuda
Publikováno v:
Cancer Research. 73:2375-2375
Background: High-grade neuroendocrine tumours (HGNTs) of the lung manifest a wide spectrum of clinical behaviour, but no method of predicting their outcome has been established. Materials and methods: We newly established a monoclonal antibody specif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ba54bf115a74b910368d5abebdc1ece
https://doi.org/10.1158/1538-7445.am2013-2375
https://doi.org/10.1158/1538-7445.am2013-2375